Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptors based on alternative signal 1 domains

Chimeric antigen receptors based on alternative signal 1 domains

US Patent 11578115 · Granted Feb 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted t cells with cytotoxicity toward immunosuppressive cells2025
Modified T cells and methods of their use2025
Modified T cells and methods of their use2025
Modification of CAR-T cells2025
Compositions and methods for immune tolerance2025
Chimeric antigen receptor T cells targeting the tumor microenvironment2025
T cells expressing a chimeric antigen receptor2024
Molecular switch-mediated control of engineered cells2024
Target peptides for immunotherapy and diagnostics2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024
Methods and compositions relating to ex vivo culture and modulation of T cells2023
Compositions and methods for detection and modulation of T cell mediated immune 2023